Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

Gilead signs deals with 6 generic drugmakers to sell HIV drug in low-income countries
Reuters
Wed, 10/2/24 - 09:55 pm
Tags:
Gilead Sciences, generics, HIV, lenacapavir
Gilead's Kite exits China cell therapy joint venture with Fosun Pharma
Fierce Pharma
Thu, 09/19/24 - 09:22 pm
Tags:
Gilead Sciences, Kite Pharma, China, Fosun Kite Biotechnology, Fosun Pharma
Kyverna swaps CEOs, leaning on Kite veterans to lead ‘next chapter’
BioPharma Dive
Mon, 09/16/24 - 10:14 pm
Tags:
Kyverna Therapeutics, Gilead Sciences, Kite Pharma, CAR-T, cell therapy
Gilead’s twice-yearly shot cut HIV infections by 96% in trial
CNBC
Thu, 09/12/24 - 10:28 am
Tags:
Gilead Sciences, HIV, lenacapavir
Gilead's Trodelvy triplet underwhelms, but bolsters company's phase 3 lung cancer design
Fierce Pharma
Mon, 09/9/24 - 07:12 pm
Tags:
Gilead Sciences, Trodelvy, non-small cell lung cancer
Avenzo and Gilead partner for breast cancer combination regimen trial
Clinical Trials Arena
Wed, 09/4/24 - 11:39 am
Tags:
Avenzo Therapeutics, Gilead Sciences, breast cancer, clinical trials, AVZO-021, Trodelvy
Galapagos Surges On An FDA Win For Its Rival To Gilead, Novartis; But There Are Some Caveats
Investors Business Daily
Mon, 08/26/24 - 11:11 am
Tags:
Galapagos, CAR-T, FDA, non-Hodgkin lymphoma, Gilead Sciences, Novartis
Gilead’s Livdelzi (Seladelpar) for Primary Biliary Cholangitis Promises Pruritus Reduction
Xtalks
Thu, 08/22/24 - 10:00 pm
Tags:
FDA, Livdelzi, Gilead Sciences, primary biliary cholangitis
FDA approves Gilead's seladelpar for primary biliary cholangitis
First Word Pharma
Wed, 08/14/24 - 10:35 pm
Tags:
Gilead Sciences, seladelpar, Livdelzi, liver disease, primary biliary cholangitis
On doorstep of FDA decision, Gilead pays J&J $320M to exit licensing deal for seladelpar
Fierce Biotech
Fri, 08/9/24 - 11:23 am
Tags:
Gilead Sciences, seladelpar, liver disease, JNJ
Gilead quarterly profit beats Street estimates, revenue up 5%
Yahoo/Reuters
Thu, 08/8/24 - 10:24 pm
Tags:
Gilead Sciences, earnings
3 Big Pharma companies, 33 phase 3 trials: The race for supremacy in an ADC field
Fierce Pharma
Mon, 08/5/24 - 11:41 am
Tags:
Merck, AstraZeneca, Gilead Sciences, clinical trials, antibody-drug conjugates
GSK’s Dovato Matches Efficacy of Gilead’s Biktarvy in Head-to-Head HIV Trial
BioSpace
Tue, 07/23/24 - 06:29 pm
Tags:
GSK, Dovato, Gilead Sciences, Biktarvy, clinical trials, HUV
A new biotech tackling IBD joins a race against Lilly and Gilead for a promising pill
Pharma Voice
Thu, 07/18/24 - 11:12 am
Tags:
Ensho Therapeutics, IBD, Gilead Sciences, Eli Lilly
Gilead’s CMO to depart next year
BioPharma Dive
Wed, 07/17/24 - 09:11 pm
Tags:
Gilead Sciences, CMOs, biotech
Gilead set to unveil data from HIV/AIDS trials
Clinical Trials Arena
Wed, 07/17/24 - 12:15 pm
Tags:
Gilead Sciences, HUV, AIDS, clinical trials
US government appeals Gilead's trial win in Truvada, Descovy patent fight
Fierce Pharma
Tue, 07/9/24 - 12:01 pm
Tags:
Gilead Sciences, HIV, PrEP, Truvada, Descovy, patents
Gilead’s Trodelvy stumbles in late-stage trials but remains prized cancer asset
BioSpace
Mon, 07/1/24 - 11:39 am
Tags:
Gilead Sciences, Trodelvy, bladder cancer, lung cancer, clinical trials
Gilead's long-acting HIV drug superior to daily pill Truvada in study
Reuters
Thu, 06/20/24 - 11:20 am
Tags:
Gilead Sciences, lenacapavir, HIV, Truvada
Gilead’s Magrolimab ineffective, linked to increased risk of death in MDS patients
BioSpace
Mon, 06/17/24 - 11:39 am
Tags:
Gilead Sciences, clinical trials, patient deaths, MDS, magrolimab

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.